Nathalie Forgeard
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
CAR T-cell expansion after idecabtagene vicleucel is a predictor of outcomes in multiple myeloma.
Journal: HemaSphere
Published: November 28, 2025
Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain Amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: November 21, 2025
Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome.
Journal: Haematologica
Published: February 18, 2025
Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients.
Journal: Journal of medical virology
Published: January 27, 2025
Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases.
Journal: British journal of haematology
Published: December 29, 2023
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series.
Journal: Blood
Published: October 16, 2023
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.
Journal: Haematologica
Published: March 16, 2023
Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: November 14, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026